New Type 2 Diabetes Study Findings Have Been Reported by Researchers at Centro Hospitalar e Universitario de Coimbra (Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established ...)

Source :: Obesity, Fitness & Wellness Week. September 12, 2020, 289
Publication Year :: 2020
Abstract: 2020 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Nutritional and Metabolic Diseases and Conditions - Type 2 [...]

Subjects :: Empagliflozin -- Research
Diabetes research -- Reports
Physical fitness -- Research -- Reports
Type 2 diabetes -- Research -- Care and treatment
Diabetes therapy -- Reports -- Research
Cardiac patients -- Care and treatment
Health

Tools